Randomised placebo controlled study of RH-GM-CSF following ALG in the treatment of aplastic anaemia.
Gordon-Smith
E C
EC
Division of Haematology, St. George's Hospital Medical School, Tooting, London, UK.
Yandle
A
A
Milne
A
A
Speck
B
B
Marmont
A
A
Willemze
R
R
Kolb
H
H
D000741:Anemia, Aplastic / Q000628:therapy*; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D001803:Blood Transfusion; D003131:Combined Modality Therapy; D004311:Double-Blind Method; D004341:Drug Evaluation; D005334:Fever / Q000517:prevention & control; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects / Q000627:therapeutic use*; D007958:Leukocyte Count / Q000187:drug effects; D017713:Platelet Transfusion; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use
D000961:Antilymphocyte Serum; D007155:Immunologic Factors; D011994:Recombinant Proteins; D016178:Granulocyte-Macrophage Colony-Stimulating Factor